Call for evidence on Dechlorane Plus™

Norway is preparing a restriction dossier on the manufacture, use and placing on the market of 1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™) [covering any of its individual anti- and synisomers or any combination thereof]. Norway invites interested parties to submit any information related to the substance to help with the preparation of the dossier.

Deadline for comments is 25 May 2020.